Correlation Between Arrowhead Pharma and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharma and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharma and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arrowhead Pharma and Allovir, you can compare the effects of market volatilities on Arrowhead Pharma and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharma with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharma and Allovir.

Diversification Opportunities for Arrowhead Pharma and Allovir

  Correlation Coefficient

Good diversification

The 3 months correlation between Arrowhead and Allovir is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharma and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Arrowhead Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharma are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Arrowhead Pharma i.e., Arrowhead Pharma and Allovir go up and down completely randomly.

Pair Corralation between Arrowhead Pharma and Allovir

Given the investment horizon of 90 days Arrowhead Pharma is expected to generate 0.68 times more return on investment than Allovir. However, Arrowhead Pharma is 1.48 times less risky than Allovir. It trades about -0.02 of its potential returns per unit of risk. Allovir is currently generating about -0.02 per unit of risk. If you would invest  6,868  in Arrowhead Pharma on July 3, 2022 and sell it today you would lose (3,563)  from holding Arrowhead Pharma or give up 51.88% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Arrowhead Pharma  vs.  Allovir

 Performance (%) 
Arrowhead Pharma 
Arrowhead Performance
0 of 100
Over the last 90 days Arrowhead Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with conflicting performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2022. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Arrowhead Price Channel

Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Arrowhead Pharma and Allovir Volatility Contrast

   Predicted Return Density   

Pair Trading with Arrowhead Pharma and Allovir

The main advantage of trading using opposite Arrowhead Pharma and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharma position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Arrowhead Pharma vs. Take-Two Interactive
Arrowhead Pharma vs. Sega Sammy Hlds
Arrowhead Pharma vs. Kyocera Corp
Arrowhead Pharma vs. Tdk Corp
The idea behind Arrowhead Pharma and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Scheid Vineyards
Allovir vs. Remy Cointreau Ff
Allovir vs. Endeavour Group
Allovir vs. Becle Sab DE
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.